Sergey Morozov’s Post

1,430 AI clearances in the US. Fewer than 1 in 10 NHS imaging departments use one beyond a pilot. Both numbers are real, and the gap between them was the honest subject of six talks at HLTH Europe.Rad in Amsterdam. Three things worth acting on: 1. Treat clearance count as a vanity metric. Dr Hugh Harvey (Hardian Health): almost every radiology clearance is a predicate me-too device, and the adverse-event tables are empty, which signals weak surveillance, not proven safety. 2. Ask a vendor for outcome evidence and an implementation plan, not a certificate. Kicky van Leeuwen (Romion Health): about 300 hours of work to field one tool, and a third of products have no publication at all. 3. Validate on your own population. Michail Klontzas, MD, PhD (University of Crete): only about 2 percent of practices use AI routinely, and the Epic sepsis model passed on paper and failed in the ward. Dr. Franz MJ Pfister, MD, MBA (deepc) showed a 10,000-study trial where AI barely moved accuracy and turnaround actually rose. Henrik Agrell (Unilabs) closed the loop: governance begins before procurement, and you select tools on your own safety data, not the vendor slide. Cleared, adopted and proven are three different purchases. Buy proof, not clearance. Swipe for the full set with sources. More of this weekly in The Imaging AI Brief, link in my profile. #radiologyAI #ClinicalAI #EUAIAct #medicalimaging #PatientSafety #aiinhealthcare

If value addition is not clear, its more cumbersome for hospitals to use AI than not to use it.

To view or add a comment, sign in

Explore content categories